- Recent Funding
- Investors
- argenx
argenx portfolio
argenx has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Unnatural Products's $45M Series B+ round in March 2026, alongside Merck Global Health Innovation Fund, Droia Ventures, ARTIS Ventures and 2 others. That company is in Health and bio.
What argenx invests in
- Health and bio · 1 · 100%
How argenx invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $45M |
argenx portfolio companies
UUnnatural Products$45MSeries B+ · Mar 2026
| Company | Round with argenx | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $45M | $77M | Mar 16, 2026 Series B+ |
Most frequent co-investors
TThe Venture Collective1 shared round · last Mar 16, 2026
DDroia Ventures1 shared round · last Mar 16, 2026
AARTIS Ventures1 shared round · last Mar 16, 2026
MMerck Global Health Innovation Fund1 shared round · last Mar 16, 2026
FFirst Spark Ventures1 shared round · last Mar 16, 2026
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name argenx. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists argenx, which is a subset of its real portfolio. API: /api/v1/investors/argenx (get a free API key). More: the most active VC firms and new venture capital funds.